Format

Send to

Choose Destination
See comment in PubMed Commons below
Science. 2008 May 2;320(5876):649-52. doi: 10.1126/science.1154690.

Practical synthesis of prostratin, DPP, and their analogs, adjuvant leads against latent HIV.

Author information

1
Department of Chemistry, Stanford University, 337 Campus Drive, Stanford, CA 94305, USA. wenderp@stanford.edu

Abstract

Although antiretroviral therapies have been effective in decreasing active viral loads in AIDS patients, the persistence of latent viral reservoirs prevents eradication of the virus. Prostratin and DPP (12-deoxyphorbol-13-phenylacetate) activate the latent virus and thus represent promising adjuvants for antiviral therapy. Their limited supply and the challenges of accessing related structures have, however, impeded therapeutic development and the search for clinically superior analogs. Here we report a practical synthesis of prostratin and DPP starting from phorbol or crotophorbolone, agents readily available from renewable sources, including a biodiesel candidate. This synthesis reliably supplies gram quantities of the therapeutically promising natural products, hitherto available only in low and variable amounts from natural sources, and opens access to a variety of new analogs.

PMID:
18451298
PMCID:
PMC2704988
DOI:
10.1126/science.1154690
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center